Dieter David 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
COLL EVP Dieter David Receives Equity Awards
What Happened
Dieter David, EVP & General Counsel of Collegium Pharmaceutical, received equity awards on February 10, 2026: 22,194 restricted stock units (RSUs) and 9,005 performance share units (PSUs) were reported as acquired (awarded) at $0.00. Concurrently, 2,781 shares were listed as disposed at $46.75 each to satisfy tax withholding obligations, a disposition valued at about $130,012. The awards are grants (not open‑market purchases) and the withholding is a routine tax-related disposition.
Key Details
- Transaction date(s): February 10, 2026 (filed February 12, 2026) — filing appears timely (filed within two business days).
- Awards: 22,194 RSUs and 9,005 PSUs granted/awarded at $0.00. The 9,005 PSUs were reported as having met performance-vesting criteria.
- Tax withholding: 2,781 shares withheld/disposed at $46.75 each for taxes (total ≈ $130,012). (Code F = tax withholding.)
- Vesting/schedule note: RSUs vest one‑third on Feb 10, 2027, with the remainder vesting in equal annual installments over the next two years, subject to continued service. PSUs were performance‑based and deemed achieved as of Feb 10, 2026.
- Additional note: Footnotes indicate 404 shares were acquired Jan 16, 2026 under the company ESPP.
- Shares owned after transaction: Not specified in the provided filing excerpt.
Context
- RSUs/PSUs are grants representing contingent rights to receive shares if vesting conditions are met; they are not cash purchases and do not directly signal the insider buying stock.
- The 2,781‑share disposition is a common cashless/tax‑withholding action when awards vest — it reduces the net shares delivered to the insider to cover tax obligations.
- This filing documents compensation-related equity activity by an insider (not an open‑market buy or sale).
Insider Transaction Report
Form 4
Dieter David
EVP & General Counsel
Transactions
- Award
Common Stock
[F1][F2]2026-02-10+22,194→ 91,047 total - Award
Common Stock
[F3]2026-02-10+9,005→ 100,052 total - Tax Payment
Common Stock
[F4]2026-02-10$46.75/sh−2,781$130,012→ 97,271 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Includes 404 shares acquired on January 16, 2026 under the Issuer's employee stock purchase plan.
- [F3]Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 9,005 performance share units ("PSUs") granted in the Issuer's 2025 fiscal year.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
Signature
/s/ Colleen Tupper as Attorney-In-Fact For David Dieter|2026-02-12